A randomized, double-blind trial on the use of a triple combination including nevirapine, a nonnucleoside reverse transcriptase HIV inhibitor, in antiretroviral-naive patients with advanced disease

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 20, Issue 1, 1999, Pages 11-19

  Floridia, M ^a   Bucciardini, R ^a   Ricciardulli, D ^a   Fragola, V ^a   Pirillo, M F ^a   Weimer, L E ^a   Tomino, C ^a   Giannini, G ^a   Galluzzo, C M ^a   Andreotti, M ^a   Cargnel, A ^b   Alberici, F ^c   De Rienzo, B ^d   Leoncini, F ^e   Fiaccadori, F ^f   Francisci, D ^g   Grillone, W ^h   Ortona, L ⁱ   Piazza, M ^j   Scalzini, A ^k   Nigra, E ^h   Tumietto, F ^l   Vella, S ^a   more..

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c Ospedale Civile   (Italy)

^d UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^e CAREGGI UNIVERSITY HOSPITAL   (Italy)

^f OSPEDALI RIUNITI   (Italy)

^g POLICLINICO MONTELUCE   (Italy)

^h AMEDEO DI SAVOIA HOSPITAL   (Italy)

ⁱ CATHOLIC UNIVERSITY   (Italy)

^j UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^k Presidio Ospedaliero   (Italy)

^l UNIVERSITY OF BOLOGNA   (Italy)

more..

Author keywords

Antiretrovital agents; Clinical trials; HIV treatment; Nevirapine; Triple combination

Indexed keywords

DIDANOSINE; NEVIRAPINE; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGED; ARTICLE; CANDIDIASIS; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; FEVER; FOLLOW UP; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; KAPOSI SARCOMA; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RASH; TOXIC EPIDERMAL NECROLYSIS; URTICARIA; VIRUS INHIBITION;

DNA VIRUSES; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0032924542     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-199901010-00002     Document Type: Article

References (13)

1. de Jong MD, Loewenthal M, Boucher CA, et al. Alternating nevirapine and zidovudine treatment of human immunodeficiency virus type 1-infected persons does not prolong nevirapine activity. J Infect Dis 1994;169:1346-50.
2. 3: AIDS Clinical Trials Group Protocol 208. J Infect Dis 1995;172:1379-83.
3. Cheeseman SH, Havlir D, McLaughlin MM, et al. Phase I/II evaluation of nevirapine alone and in combination with zidovudine for infection with human immunodeficiency virus. J Acquir Immune Defic Syndr Hum Retrovirol, 1995;8:141-51.
4. Havlir D, Cheeseman SH, McLaughlin M, et al. High-dose nevirapine: safety, pharmacokinetics, and antiviral effect in patients with human immunodeficiency virus infection. J Infect Dis 1995; 171:537-45.
5. de Jong MD, Vella S, Carr A, et al. High-dose nevirapine in previously untreated human immunodeficiency virus type 1-infected persons does not result in sustained suppression of viral replication. J Infect Dis 1997;175:966-70.
6. Carr A, Vella S, de Jong MD, et al. A controlled trial of nevirapine plus zidovudine versus zidovudine alone in p24 antigenaemic HIV-infected patients. The Dutch-Italian-Australian Nevirapine Study Group. AIDS 1996;10:635-41.
7. D'Aquila RT, Hughes MD, Johnson VA, et al. Nevirapine, zidovudine, and didanosine compared with zidovudine and didanosine in patients with HIV-1 infection. A randomized, double-blind, placebo-controlled trial. National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group Protocol 241 Investigators. Ann Intern Med 1996;124:1019-30.
8. Montaner JSG, Conway B, Reiss P, et al. A randomized, double blind trial comparing combinations of nevirapine, didanosine and zidovudine for HIV infected patients. The INCAS Trial. JAMA 1998;279:930-7.
9. 1993 Revised CDC HIV classification system and expanded AIDS surveillance definition for adolescents and adults. MMWR Morb Mortal Wkly Rep 1992;41:RR-17.
10. van Gemen B, Kievits T, Nara P, et al. Qualitative and quantitative detection of HIV-1 RNA by nucleic acid sequence-based amplification. AIDS 1993;7(Suppl 2):S107-10.
11. Hand DJ, Crowder M. Practical longitudinal data analysis. New York: Chapman and Hall, 1996.
12. Carpenter CCJ, Fischl MA, Hammer SM, et al. Antiretroviral therapy for HIV infection in 1997. Updated recommendations of the International AIDS Society-USA panel. JAMA 1997;277: 1962-9.
13. Nevirapine (Viramune)prescribing information leaflet. Ridgefield, CT: Boehringer Ingelheim Pharmaceuticals.